ACI Respond to NPA Statement in CBD Regulation
Steve Moore, ACI Strategic Counsel has today responded to the National Pharmacy Association’s advisory statement regarding CBD products in pharmacies with the following statement:
Play Video
Who we are
Nuturing a safe, legal and flourishing consumer cannabis extract market
The Association for the Cannabinoid Industry (ACI) is a membership organisation for businesses committed to nurturing a safe, legal and flourishing consumer cannabis extract market in the UK and Europe.
The UK has the world’s most developed regulatory framework for legal cannabinoids. This market is estimated to be worth £690 million ($1 billion) in 2021, making it the second largest in the world after the US.
What we do
Securing regulatory compliance for our members
Toxicological Data
Cost-effective access to toxicological data required to gain novel foods authorisation from FSA (UK) and EFSA (EU).
Representation
We represent our members at the highest level so their voice is heard and a favourable regulatory environment exists.
Technical Consultancy
Our team of industry experts offer bespoke consultancy solutions to support our members.
Food Standards Authority Novel Foods
We have successfully assisted brands in their continued authorisation for sale within the UK
As of 31 March 2022, the UK has become the first country in the world to apply regulation to products containing CBD through the Food Standards Agency (FSA) Novel Foods authorisation process. 69% of all applications on the FSA’s public list can be linked to ACI’s CBD safety consortium. 100% of ACI member applications successfully appeared on this list.
As the leading trade body for the cannabinoid industry we are here to help your business in its next steps within this rapidly growing market. To find out more, contact us via the button below, or call us on 0800 310 10 54.
Membership
Our membership offering
ACI helped 100% of our members get on the FSA’s public list of CBD products permitted to be sold in the UK. In fact, 69% of all applications on the FSA’s list are linked to ACI’s CBD safety consortium.
If you are facing challenges meeting the FSA’s requirements to legally sell cannabinoid extracts in the UK the ACI can help.
We offer our members
- – Representation – We represent our members at the highest level so their voice is heard and a favourable regulatory environment exists
- – Data – Cost-effective access to toxicological data required to gain novel foods authorisation from FSA (UK) and EFSA (EU)
- – Technical consultancy – Our team of industry experts offer bespoke consultancy solutions to support our members
If you are already established or looking to enter the UK’s legal cannabinoid market ACI membership can benefit you.
ACI offers solutions for raw material suppliers, manufacturers, brands, retailers and others operating in this space.
Industry Representation
Toxicological Data
Industry Expertise
Trading Standards Partnership
Networking Opportunities
News
Latest ACI related news & statements
ACI to Commence Novels Foods Applications for our Members
Deadline for acknowledgement of engagement from ACI members in the Novel Foods application process set to 20 December. This is the first major step towards a fully-compliant CBD industry in…
Association for the Cannabinoid Industry announced as a Diamond Sponsor at The Grocer’s inaugural CBD Global Summit in spring 2020
The Association for the Cannabinoid Industry (ACI) is delighted to announce its partnership with The Grocer as a diamond sponsor for the publication’s first ever CBD Global Summit on the…
Our team
Meet the ACI team
Steve Moore
Strategic Counsel
Dr Parveen Bhatarah
Regulatory and Compliance Associate
Dr Paul Duffy
Toxicology Associate
Dr Andy Yates
Pharmacy Associate
Róisín Delaney
Communications Associate
Richard Clarke
PR & Communications Advisor
Zehra Zahir
Company Secretary
Jo Sexton
Member Manager
Victoria Logan
Events and Social Content Associate
Laura Williamson
Technical Advisor
Tom Risby
Political Intern
Paul Birch
Founder
Bill Griffin
Communications Associate, Brussels
Leila Simpson
Innovation Director, Lisbon
Previous
Next
